Treating BD and BCF cells with 3‐oxo‐C12‐HSL led to significant calcium mobilization that was abrogated in TAS2R14‐knockdown (KD) cells, demonstrating a TAS2R14‐dependent mechanism [114]. Here, TAS2R14 is linked to Behcet disease.